Ergi D, Kahraman U, Akkus G, Durmaz S, Balcioglu O, Engin C
Diagnostics (Basel). 2023; 13(22).
PMID: 37998596
PMC: 10670598.
DOI: 10.3390/diagnostics13223460.
Aghamohammadi D, Shakouri S, Jahanpanah N, Dolatkhah N
Med Gas Res. 2023; 14(2):67-74.
PMID: 37929510
PMC: 10715328.
DOI: 10.4103/2045-9912.385439.
Khadzhieva M, Kolobkov D, Kashatnikova D, Gracheva A, Redkin I, Kuzovlev A
Biomolecules. 2023; 13(9).
PMID: 37759780
PMC: 10526997.
DOI: 10.3390/biom13091380.
Casanova J, Hammarstrom L
J Clin Immunol. 2023; 43(4):671-674.
PMID: 37010672
DOI: 10.1007/s10875-023-01446-2.
Skouboe M, Werner M, Mogensen T
Pathogens. 2023; 12(2).
PMID: 36839582
PMC: 9961685.
DOI: 10.3390/pathogens12020310.
A Review of Different Types of Liposomes and Their Advancements as a Form of Gene Therapy Treatment for Breast Cancer.
Tseu G, Kamaruzaman K
Molecules. 2023; 28(3).
PMID: 36771161
PMC: 9920768.
DOI: 10.3390/molecules28031498.
Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.
Antoli A, Rocamora-Blanch G, Framil M, Mas-Bosch V, Navarro S, Bermudez C
Front Immunol. 2022; 13:895209.
PMID: 35572562
PMC: 9098934.
DOI: 10.3389/fimmu.2022.895209.
Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network.
Cirillo E, Polizzi A, Soresina A, Prencipe R, Giardino G, Cancrini C
J Clin Immunol. 2022; 42(4):783-797.
PMID: 35257272
PMC: 9166859.
DOI: 10.1007/s10875-022-01234-4.
Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study.
Hernandez A, Vinals M, Pablos A, Vilas F, Papadakos P, Wijeysundera D
Int Immunopharmacol. 2020; 90:107261.
PMID: 33310665
PMC: 7833586.
DOI: 10.1016/j.intimp.2020.107261.
Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia.
Hernandez A, Vinals M, Isidoro T, Vilas F
Am J Case Rep. 2020; 21:e925849.
PMID: 32804917
PMC: 7476746.
DOI: 10.12659/AJCR.925849.
Primary Immunodeficiencies: Diseases of Children and Adults - A Review.
Lewandowicz-Uszynska A, Pasternak G, Swierkot J, Bogunia-Kubik K
Adv Exp Med Biol. 2020; 1289:37-54.
PMID: 32803731
DOI: 10.1007/5584_2020_556.
Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation.
Cabral-Marques O, Schimke L, de Oliveira Jr E, El Khawanky N, Ramos R, Al-Ramadi B
Front Immunol. 2019; 10:2742.
PMID: 31849949
PMC: 6889851.
DOI: 10.3389/fimmu.2019.02742.
Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway.
Garcia-Laorden M, Hernandez-Brito E, Munoz-Almagro C, Pavlovic-Nesic S, Rua-Figueroa I, Briones M
J Clin Immunol. 2019; 40(1):203-210.
PMID: 31828694
PMC: 7223972.
DOI: 10.1007/s10875-019-00714-4.
Peripheral Neuropathy Due to Common Variable Immunodeficiency: Case Report and Narrative Review.
Long C, Suzuki H, Vitale K
Gerontol Geriatr Med. 2019; 5:2333721419850644.
PMID: 31192279
PMC: 6539564.
DOI: 10.1177/2333721419850644.
The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.
de Jong S, Crequer A, Matos I, Hum D, Gunasekharan V, Lorenzo L
J Exp Med. 2018; 215(9):2289-2310.
PMID: 30068544
PMC: 6122964.
DOI: 10.1084/jem.20170308.
Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.
de Jong S, Imahorn E, Itin P, Uitto J, Orth G, Jouanguy E
Front Microbiol. 2018; 9:1222.
PMID: 29946305
PMC: 6005841.
DOI: 10.3389/fmicb.2018.01222.
International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity.
Picard C, Gaspar H, Al-Herz W, Bousfiha A, Casanova J, Chatila T
J Clin Immunol. 2017; 38(1):96-128.
PMID: 29226302
PMC: 5742601.
DOI: 10.1007/s10875-017-0464-9.
Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.
Boisson B, Quartier P, Casanova J
Curr Opin Immunol. 2015; 32:90-105.
PMID: 25645939
PMC: 4364384.
DOI: 10.1016/j.coi.2015.01.005.
Efficacy and safety of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with primary immunodeficiency diseases.
Kanegane H, Imai K, Yamada M, Takada H, Ariga T, Bexon M
J Clin Immunol. 2014; 34(2):204-11.
PMID: 24504846
PMC: 3937544.
DOI: 10.1007/s10875-013-9985-z.
The MECP2 duplication syndrome.
Ramocki M, Tavyev Y, Peters S
Am J Med Genet A. 2010; 152A(5):1079-88.
PMID: 20425814
PMC: 2861792.
DOI: 10.1002/ajmg.a.33184.